ID | CAS | Name | Synonyms | Molecular Formula | Category |
---|---|---|---|---|---|
1 | 1189881-87-5 | Bisoprolol-d5 | Bisoprolol-d5 [2H5]-Bisoprolol | ||
2 | 111051-40-2 | R-(+)-BISOPROLOL | R-(+)-BISOPROLOL 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (R)- 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (2R)- | ||
3 | 774603-04-2 | 10-Nitrolinoleate | 10-Nitrolinoleate | ||
4 | 2226263-68-7 | Bisoprolol Impurity | Bisoprolol Impurity Bisoprolol Impurity 39 | ||
5 | SUCCINIMIDYL MYRISTATE | SUCCINIMIDYL MYRISTATE | |||
6 | 1797132-90-1 | Bisoprolol EP Impurity C | Bisoprolol EP Impurity C | ||
7 | BISOPROLOL MM(CRM STANDARD) | BISOPROLOL MM(CRM STANDARD) | |||
8 | 69888-86-4 | Myristic acid N-hydroxysuccinimide ester | Myr-OSu N-Succinimidyl Myristate N-Succinimidyl Tetradecanoate N-Hydroxysuccinimide myristate 2,5-Dioxopyrrolidin-1-yl tetradecanoate Myristic acid N-hydroxysuccinimide ester Tetradecanoic acid N-hydroxysuccinimide ester 1-[(1-oxotetradecyl)oxy]-2,5-Pyrrolidinedione | ||
9 | Bisoprolol for system suitability method A | Bisoprolol for system suitability method A | |||
10 | 1417651-32-1 | 9(E),11(E)-9-nitro Conjugated Linoleic Acid | 9(E),11(E)-9-nitro Conjugated Linoleic Acid | ||
11 | 503610-29-5 | N-(3-Oxotetradecanoyl)-DL-homoserine lactone | N-(3-Oxotetradecanoyl)-DL-homoserine lactone | ||
12 | N-(3-hydroxy-7-tetradecenoyl)homoserine lactone | N-(3-hydroxy-7-tetradecenoyl)homoserine lactone | |||
13 | 482598-46-9 | N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone | N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone | ||
14 | 273734-65-9 | N-(3-hydroxy-7-cis tetradecenoyl)-L-Homoserine lactone | (S)-N-3-hydroxy-(7Z)-tetradecenoyl-homoserine lactone N-(3-hydroxy-7-cis tetradecenoyl)-L-Homoserine lactone | ||
15 | 394734-83-9 | (S)-di-tert-butyl2-azaspiro[4.4]nonane-2,3-dicarboxylate | (S)-di-tert-butyl2-azaspiro[4.4]nonane-2,3-dicarboxylate | ||
16 | 5-Nonyl-10-methylene-5-aza-2,8-dioxacycloundecane-1,9-dione | 5-Nonyl-10-methylene-5-aza-2,8-dioxacycloundecane-1,9-dione | |||
17 | 3-TERT-BUTYL 9-ETHYL 3-AZASPIRO[5.5]UNDECANE-3,9-DICARBOXYLATE | 3-TERT-BUTYL 9-ETHYL 3-AZASPIRO[5.5]UNDECANE-3,9-DICARBOXYLATE | |||
18 | 66722-44-9 | 1-[isopropylamino]-3-[isopropoxyethoxymethylphenoxy]-2-propanol | BISOPROLOL Bisoprolol Bisoprolol base Bisoprolol-d5 HeMifuMarate 1-[isopropylamino]-3-[isopropoxyethoxymethylphenoxy]-2-propanol 1-{4-[(2-Isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)-2-propanol 1-(4-((2-isopropoxyethoxy)Methyl)phenoxy)-3-(isopropylaMino)propan-2-ol (R)-1-(Isopropylamino)-3-[4-(2-isopropoxyethoxymethyl)phenoxy]-2-propanol 1-[(1-Methylethyl)amino]-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-2-propanol (R)-1-[(1-Methylethyl)amino]-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-2-propanol 1-{4-[(2-Isopropoxyethoxy)methyl]phenoxy}-3-( isopropylamino)-2-propanol fumaric acid salt | ||
19 | 1-[4-[(2-Propoxyethoxy)methyl]phenoxy]-3-(isopropylamino)-2-propanol | 1-[4-[(2-Propoxyethoxy)methyl]phenoxy]-3-(isopropylamino)-2-propanol | |||
20 | (RS)-1-IsopropylaMino-3-[4-(2-propoxyethoxyMethyl)phenoxy]propan-2-ol | Bisoprolol IMpurity B (RS)-1-IsopropylaMino-3-[4-(2-propoxyethoxyMethyl)phenoxy]propan-2-ol | |||
21 | N-[3-(Acetyloxy)-2,2-dimethylpropionyl]-N-butyl-2,3-dimethyl-4-pentenamide | N-[3-(Acetyloxy)-2,2-dimethylpropionyl]-N-butyl-2,3-dimethyl-4-pentenamide | |||
22 | Pivalic acid [(4E,6Z)-8-[(tert-butyloxycarbonyl)amino]-4,6-octadienyl] ester | Pivalic acid [(4E,6Z)-8-[(tert-butyloxycarbonyl)amino]-4,6-octadienyl] ester | |||
23 | 539823-39-7 | (2R)-1-[(1-Methylethyl)amino]-3-[4-[(2-propoxyethoxy)methyl]phenoxy]-2-propanol | Bisoprolol EP Impurity B Bisoprolol impurities1628 (2R)-1-[(1-Methylethyl)amino]-3-[4-[(2-propoxyethoxy)methyl]phenoxy]-2-propanol 2-Propanol, 1-[(1-methylethyl)amino]-3-[4-[(2-propoxyethoxy)methyl]phenoxy]-, (2R)- | ||
24 | 4-TERT-BUTOXYCARBONYLMETHYL-3-VINYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | 4-TERT-BUTOXYCARBONYLMETHYL-3-VINYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | |||
25 | 1447715-44-7 | Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate) | Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate) | ||
26 | 1346229-41-1 | 3-Azaspiro[5.5]undecane-9-acetic acid, 3-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester | 3-Azaspiro[5.5]undecane-9-acetic acid, 3-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester | ||
27 | 103691-23-2 | Acrylic acid 3-ethyl-8,8,10,10-tetramethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-ylmethyl ester | (3-ethyl-8,8,10,10-tetramethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl prop-2-enoate Acrylic acid 3-ethyl-8,8,10,10-tetramethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-ylmethyl ester | ||
28 | (3E,4E)-3-[[(Diisopropylamino)carbonyloxy]methylene]-2,4-dimethyl-4-hexenoic acid ethyl ester | (3E,4E)-3-[[(Diisopropylamino)carbonyloxy]methylene]-2,4-dimethyl-4-hexenoic acid ethyl ester | |||
29 | (3E,4E)-3-[[(Diisopropylamino)carbonyloxy]methylene]-4,6-dimethyl-4-heptenoic acid methyl ester | (3E,4E)-3-[[(Diisopropylamino)carbonyloxy]methylene]-4,6-dimethyl-4-heptenoic acid methyl ester | |||
30 | 39818-21-8 | Butanoic acid, 3-methyl-, hexahydro-7-((3-methyl-1-oxobutoxy)methyl)-1 H-pyrrolizin-1-yl ester, (1R-(1alpha,7alpha,7abeta))- | Butanoic acid, 3-methyl-, hexahydro-7-((3-methyl-1-oxobutoxy)methyl)-1 H-pyrrolizin-1-yl ester, (1R-(1alpha,7alpha,7abeta))- |
ID | CAS | Product Name | Suppliers | Descriptions |
---|